Compare · CGC vs OBIO
CGC vs OBIO
Side-by-side comparison of Canopy Growth Corporation (CGC) and Orchestra BioMed Holdings Inc. (OBIO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CGC and OBIO operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- CGC is the larger of the two at $2.86B, about 12.0x OBIO ($237.7M).
- OBIO has been more active in the news (6 items in the past 4 weeks vs 1 for CGC).
- CGC has more recent analyst coverage (19 ratings vs 9 for OBIO).
- Company
- Canopy Growth Corporation
- Orchestra BioMed Holdings Inc.
- Price
- $1.13+0.90%
- $3.94-1.00%
- Market cap
- $2.86B
- $237.7M
- 1M return
- +14.83%
- -
- 1Y return
- -15.73%
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 1
- 6
- Recent ratings
- 19
- 9
Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Latest CGC
- 'There's a Tweed for That': Canopy Growth Announces Tweed Brand Summer Campaign
- SEC Form 4 filed by Yanofsky Theresa
- SEC Form 4 filed by Atkins M Shan
- SEC Form 4 filed by Bayern Joseph
- SEC Form 4 filed by Lazzarato David Angelo
- Canopy Growth Unveils New Brand 'Deelish': High THC, Everyday Price
- Canopy Growth's Apollo Cannabis Clinics Named Best Medical Cannabis Clinic
- Canaccord Genuity initiated coverage on Canopy Growth
- Canopy Growth Announces Storz & Bickel Executive Transition
- Canopy Growth Corporation filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Latest OBIO
- FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
- Amendment: SEC Form SCHEDULE 13D/A filed by Orchestra BioMed Holdings Inc.
- Large owner Rtw Investments, Lp exercised 1,250,032 in-the-money shares at a strike of $0.00 and sold $132 worth of shares (32 units at $4.13) (SEC Form 4)
- SEC Form DEFA14A filed by Orchestra BioMed Holdings Inc.
- SEC Form DEF 14A filed by Orchestra BioMed Holdings Inc.
- Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
- SEC Form 4 filed by Sherman Darren
- SEC Form 4 filed by Aiello Joshua
- SEC Form 4 filed by Hochman David P
- Officer Hochman David P bought $42,900 worth of shares (10,000 units at $4.29), increasing direct ownership by 0.93% to 1,086,467 units (SEC Form 4)